Kim Forest eyes approval for non-invasive virus test
Kim Forest Enterprise Co (金萬林), which focuses on molecular testing, yesterday said it has applied to receive marketing approval for its non-invasive polymerase chain reaction (PCR) test products, hoping to meet rising demand for COVID-19 test kits as cases in Taiwan rise. The company’s reagents that obtained regulatory approval in June 2020 test material from a person’s nasal cavity and pharynx, while its latest reagents test saliva, allowing pain-free sample collection, Kim Forest Enterprise said in a statement. “We hope that this new product, if approved, can ease the pain and th...